Bright Minds Biosciences
Bright Minds Biosciences is a US-based biotech company specializing in the development of innovative therapeutics to treat neurological and psychiatric disorders. The company focuses on novel drug candidates that precisely target serotonin receptors to advance treatments for mental health conditions.
Frequently asked questions
When did Bright Minds Biosciences last report quarterly earnings?
Bright Minds Biosciences last reported quarterly earnings on 8/14/2026 (Q2 2026). Earnings per share (EPS) came in at -0.17 USD.
How often has Bright Minds Biosciences beaten expectations?
Bright Minds Biosciences has beaten analyst EPS estimates in 5 of its last 5 evaluated quarters (beat rate: 100%).
How do I add the Bright Minds Biosciences earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.